David A. Abernethy
Wellington, WGN 6021, New Zealand
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Vitamin D did not reduce multiple sclerosis disease activity after a clinically isolated syndrome.
Journal: Brain : a journal of neurology
Published: August 08, 2023
Atypical presentations of immune-mediated necrotizing myopathy: Clues and caveats.
Journal: Muscle & nerve
Published: February 03, 2022
The latitude gradient for multiple sclerosis prevalence is established in the early life course.
Journal: Brain : a journal of neurology
Published: October 16, 2020
Safety and acceptability of clozapine and risperidone in progressive multiple sclerosis: a phase I, randomised, blinded, placebo-controlled trial.
Journal: BMJ neurology open
Published: March 23, 2020
Relapse Patterns in NMOSD: Evidence for Earlier Occurrence of Optic Neuritis and Possible Seasonal Variation.
Journal: Frontiers in neurology
Published: March 12, 2020
The clinical profile of NMOSD in Australia and New Zealand.
Journal: Journal of neurology
Published: November 05, 2019
Multiple Sclerosis impact on employment and income in New Zealand.
Journal: Acta neurologica Scandinavica
Published: November 09, 2016
Incidence and prevalence of NMOSD in Australia and New Zealand.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: September 02, 2016
Glatiramer acetate treatment normalized the monocyte activation profile in MS patients to that of healthy controls.
Journal: Immunology and cell biology
Published: July 19, 2016
Faciobrachial dystonic seizures in an Lgi1 VGKC-complex antibody-mediated encephalitis.
Journal: Neurology. Clinical practice
Published: December 01, 2015
An investigation of the relationship between latitude and multiple sclerosis severity in New Zealand.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: October 04, 2015
Last Updated: 09/26/2026